Avandia Should Remain Available: FDA Official
On December 4, 2008, a top level FDA official said GlaxoSmithKline PLC's diabetes drug Avandia should remain available to patients despite some medical associations' calls for doctors not to use it.
Janet Woodcock, head of the FDA's Center for Drug Evaluation and Research, said in an interview that people have "convicted" ...
